Pharmacotherapy of Chronic Pulmonary Arterial Hypertension: Value and Limitations-Reference-Cited by-同舟云学术

Pharmacotherapy of Chronic Pulmonary Arterial Hypertension: Value and Limitations

Published:1994-08 Issue:8 Volume:45 Page:667-676
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Alpert Martin A.¹,Concannon Milton D.¹,Mukerji Basanti¹,Mukerji Vaskar¹

Affiliation:

1. Division of Cardiology, University of South Alabama, College of Medicine, Mobile, Alabama

Abstract

Efforts aimed at assessing pharmacotherapy of pulmonary arterial hypertension (PHT) have largely focused on patients with primary PHT, PHT associated with selected connec tive tissue diseases, and various forms of hypoxic secondary PHT. Part I of this review discusses the value and limitations of a wide variety of vasodilator drugs, oxygen, and warfarin in the treatment of primary PHT with special reference to their effects on pulmonary and systemic hemodynamics, functional capacity, and survival.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/000331979404500801

Reference94 articles.

1. Grossman W., Braunwald E.: Pulmonary hypertension. In: Heart Disease: A Textbook of Cardiovascular Disease, ed. 4, ed by Braunwald E. Philadelphia : W. B. Saunders Co, 1992, pp 790-818.

2. Management of primary pulmonary hypertension.

3. Vasodilator Therapy for Primary Pulmonary Hypertension

4. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.

5. Primary pulmonary hypertension: natural history and the importance of thrombosis.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adrenoceptors and Hypertension;Handbook of Experimental Pharmacology;2024

2. Effects of bergapten on the pharmacokinetics of macitentan in rats both in vitro and in vivo;Frontiers in Pharmacology;2023-07-10

3. The β 2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via a adrenoceptor antagonism;The FASEB Journal;2018-01-02

4. α1-adrenoceptor subtypes mediating noradrenaline-induced contraction of pulmonary artery from pulmonary hypertensive rats;European Journal of Pharmacology;2003-12

5. Medikamentöse Langzeitbehandlung der pulmonalen Hypertonie;DMW - Deutsche Medizinische Wochenschrift;2001-12-31